• Nenhum resultado encontrado

A Phase I Double Blind, Placebo-Controlled, Randomized Study of the Safety and Immunogenicity of an Adjuvanted HIV-1 Gag-Pol-Nef Fusion Protein and Adenovirus 35 Gag-RT-Int-Nef Vaccine in Healthy HIV-Uninfected African Adults.

N/A
N/A
Protected

Academic year: 2017

Share "A Phase I Double Blind, Placebo-Controlled, Randomized Study of the Safety and Immunogenicity of an Adjuvanted HIV-1 Gag-Pol-Nef Fusion Protein and Adenovirus 35 Gag-RT-Int-Nef Vaccine in Healthy HIV-Uninfected African Adults."

Copied!
27
0
0

Texto

Loading

Referências

Documentos relacionados

Tribulus terrestris for treatment of sexual dysfunction in women: randomized double-blind placebo - controlled study. Androgens and the ageing male

Na concepção do programa considerou-se que a informação a enviar para o robot era a seguinte: ins- trução, duração da instrução; a próxima posição da instrução, dependendo

To examine the effects of HIV-1 Nef expression on viral replication and transmission in a physiologically relevant system, HIV-1 infection of activated PBLs and DC-mediated

responses against Gag GW9 and Nef RM9 antigens in a conventional (18 h) and an extended IFN- c ELISPOT assay. Due to limited numbers of cells per sample and limited resources

A multicenter, randomized, double-blind, placebo-controlled study of eficacy and safety of 3 doses of botulinum toxin A in the treatment of glabellar lines.. Rzany

This was a randomized, double-blind, placebo-controlled study, with the aim of evaluating the eficacy and safety of cumaru syrup as complementary therapy in mild persistent

This double-blind, randomized, placebo-controlled clinical trial is the irst study to evaluate the toxicology and safety of tincture of O. alata in patients with

As both cytokines are prominent representatives of type 2 inflammatory reactions, we performed a double-blind, placebo-controlled randomized study on the effectiveness and safety